Radius Health (RDUS) Tops Q2 EPS by 7c
Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.59), $0.07 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $674 million versus the consensus estimate of $693.9 million.
For earnings history and earnings-related data on Radius Health (RDUS) click here.
